Skip to main content
SpringerLink
Log in

Interventional Management of Acute Myocardial Infarction

  • Chapter
  • First Online:
Textbook of Cardiovascular Intervention

  • 2645 Accesses

Abstract

Coronary artery disease is the leading cause of death in the United States and was responsible for approximately one of every six deaths in the United States in 2008. Each year, an estimated 785,000 Americans will have an ST segment elevation myocardial infarction (STEMI), and ≈470,000 will have a repeat event. Roughly every 25 s, an American will have a STEMI, and approximately every minute, a STEMI will be the cause of a death (Roger et al. Circulation 125(1):e2–e220). Acute thrombotic occlusion is the predominant pathophysiological cause of STEMI and also forms the rationale for reperfusion therapy, either thrombolysis or primary percutaneous coronary intervention (PCI).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Roger VL, et al. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation. 2012;125(1):e2–220.

    Article  PubMed  Google Scholar 

  2. Fibrinolytic Therapy Trialists’ (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet. 1994;343(8893):311–22.

    Google Scholar 

  3. Chesebro JH, et al. Thrombolysis in Myocardial Infarction (TIMI) trial, phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation. 1987;76(1):142–54.

    Article  PubMed  CAS  Google Scholar 

  4. Straznicky IT, White HD. Thrombolytic therapy for acute myocardial infarction in the elderly. Coron Artery Dis. 2000;11(4):299–304.

    Article  PubMed  CAS  Google Scholar 

  5. O’Neill W, et al. A prospective randomized clinical trial of intracoronary streptokinase versus coronary angioplasty for acute myocardial infarction. N Engl J Med. 1986;314(13):812–8.

    Article  PubMed  Google Scholar 

  6. Grines CL, et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med. 1993;328(10):673–9.

    Article  PubMed  CAS  Google Scholar 

  7. Zijlstra F, et al. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med. 1993;328(10):680–4.

    Article  PubMed  CAS  Google Scholar 

  8. de Boer MJ, et al. Immediate coronary angioplasty versus intravenous streptokinase in acute myocardial infarction: left ventricular ejection fraction, hospital mortality and re-infarction. J Am Coll Cardiol. 1994;23(5):1004–8.

    Article  PubMed  Google Scholar 

  9. The Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO IIb) Angioplasty Substudy Investigators. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. N Engl J Med. 1997;336(23):1621–8.

    Google Scholar 

  10. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003;361(9351):13–20.

    Article  PubMed  Google Scholar 

  11. Stone GW, et al. Influence of acute myocardial infarction location on in-hospital and late outcome after primary percutaneous transluminal coronary angioplasty versus tissue plasminogen activator therapy. Am J Cardiol. 1996;78(1):19–25.

    Article  PubMed  CAS  Google Scholar 

  12. Henriques JP, et al. Primary percutaneous coronary intervention versus thrombolytic treatment: long term follow up according to infarct location. Heart. 2006;92(1):75–9.

    Article  PubMed  CAS  Google Scholar 

  13. Magid DJ, et al. Relation between hospital primary angioplasty volume and mortality for patients with acute MI treated with primary angioplasty vs thrombolytic therapy. JAMA. 2000;284(24):3131–8.

    Article  PubMed  CAS  Google Scholar 

  14. Canto JG, et al. The volume of primary angioplasty procedures and survival after acute myocardial infarction. National Registry of Myocardial Infarction 2 Investigators. N Engl J Med. 2000;342(21):1573–80.

    Article  PubMed  CAS  Google Scholar 

  15. Kastrati A, et al. Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction. Eur Heart J. 2007;28(22):2706–13.

    Article  PubMed  Google Scholar 

  16. De Luca G, et al. Efficacy and safety of drug-eluting stents in ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. Int J Cardiol. 2009;133(2):213–22.

    Article  PubMed  Google Scholar 

  17. Stone GW, et al. Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction. N Engl J Med. 2009;360(19):1946–59.

    Article  PubMed  CAS  Google Scholar 

  18. Nallamothu BK, Bates ER. Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: is timing (almost) everything? Am J Cardiol. 2003;92(7):824–6.

    Article  PubMed  Google Scholar 

  19. Boersma E. Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital thrombolysis in acute myocardial infarction patients. Eur Heart J. 2006;27(7):779–88.

    Article  PubMed  Google Scholar 

  20. Nallamothu BK, et al. Driving times and distances to hospitals with percutaneous coronary intervention in the United States: implications for prehospital triage of patients with ST-elevation myocardial infarction. Circulation. 2006;113(9):1189–95.

    Article  PubMed  Google Scholar 

  21. Chakrabarti A, et al. Time-to-reperfusion in patients undergoing interhospital transfer for primary percutaneous coronary intervention in the U.S: an analysis of 2005 and 2006 data from the National Cardiovascular Data Registry. J Am Coll Cardiol. 2008;51(25):2442–3.

    Article  PubMed  Google Scholar 

  22. Nallamothu BK, et al. Times to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United States: National Registry of Myocardial Infarction (NRMI)-3/4 analysis. Circulation. 2005;111(6):761–7.

    Article  PubMed  Google Scholar 

  23. Kushner FG, et al. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2009;54(23):2205–41.

    Article  PubMed  Google Scholar 

  24. Van de Werf F, et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J. 2008;29(23):2909–45.

    Article  PubMed  Google Scholar 

  25. Ting HH, et al. Regional systems of care to optimize timeliness of reperfusion therapy for ST-elevation myocardial infarction: the Mayo Clinic STEMI Protocol. Circulation. 2007;116(7):729–36.

    Article  PubMed  Google Scholar 

  26. Andersen HR, et al. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med. 2003;349(8):733–42.

    Article  PubMed  Google Scholar 

  27. Widimsky P, et al. Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial–PRAGUE-2. Eur Heart J. 2003;24(1):94–104.

    Article  PubMed  CAS  Google Scholar 

  28. Grines CL, et al. A randomized trial of transfer for primary angioplasty versus on-site thrombolysis in patients with high-risk myocardial infarction: the Air Primary Angioplasty in Myocardial Infarction study. J Am Coll Cardiol. 2002;39(11):1713–9.

    Article  PubMed  Google Scholar 

  29. De Luca G, Biondi-Zoccai G, Marino P. Transferring patients with ST-segment elevation myocardial infarction for mechanical reperfusion: a meta-regression analysis of randomized trials. Ann Emerg Med. 2008;52(6):665–76.

    Article  PubMed  Google Scholar 

  30. Henry TD, et al. A regional system to provide timely access to percutaneous coronary intervention for ST-elevation myocardial infarction. Circulation. 2007;116(7):721–8.

    Article  PubMed  Google Scholar 

  31. Cantor WJ, et al. Routine early angioplasty after thrombolysis for acute myocardial infarction. N Engl J Med. 2009;360(26):2705–18.

    Article  PubMed  Google Scholar 

  32. Di Mario C, et al. Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomised, multicentre trial. Lancet. 2008;371(9612):559–68.

    Article  PubMed  Google Scholar 

  33. Cannon CP, et al. TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: results of the TIMI 10B trial. Thrombolysis in Myocardial Infarction (TIMI) 10B Investigators. Circulation. 1998;98(25):2805–14.

    Article  PubMed  CAS  Google Scholar 

  34. Cannon CP, et al. TNK-tissue plasminogen activator in acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) 10A dose-ranging trial. Circulation. 1997;95(2):351–6.

    Article  PubMed  CAS  Google Scholar 

  35. Sabatine MS, et al. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med. 2005;352(12):1179–89.

    Article  PubMed  CAS  Google Scholar 

  36. Chen ZM, et al. Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet. 2005;366(9497):1607–21.

    Article  PubMed  CAS  Google Scholar 

  37. Larson DM, et al. Safety and efficacy of a pharmaco-invasive reperfusion strategy in rural ST-elevation myocardial infarction patients with expected delays due to long-distance transfers. Eur Heart J. 2012;33(10):1232–40.

    Article  PubMed  CAS  Google Scholar 

  38. Hochman JS, et al. Coronary intervention for persistent occlusion after myocardial infarction. N Engl J Med. 2006;355(23):2395–407.

    Article  PubMed  CAS  Google Scholar 

  39. Van de Werf F, et al. Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (Assent-4 PCI): randomized trial. Lancet. 2006;367(9510):569–78.

    Article  Google Scholar 

  40. Ross AM, et al. The impact of place of enrollment and delay to reperfusion on 90-day post-infarction mortality in the ASSENT-4 PCI trial: assessment of the safety and efficacy of a new treatment strategy with percutaneous coronary intervention. JACC Cardiovasc Interv. 2009;2(10):925–30.

    Article  PubMed  Google Scholar 

  41. Ellis SG, et al. Facilitated PCI in patients with ST-elevation myocardial infarction. N Engl J Med. 2008;358(8):2205–17 (Is this FINESSE?).

    Article  PubMed  CAS  Google Scholar 

  42. Herrmann HC, et al. Benefit of facilitated percutaneous coronary intervention in high-risk ST-segment elevation myocardial infarction patients presenting to nonpercutaneous coronary intervention hospitals. JACC Cardiovasc Interv. 2009;2(10):917–24.

    Article  PubMed  Google Scholar 

  43. Antman EM, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction). J Am Coll Cardiol. 2004;44(3):671–719.

    Article  PubMed  Google Scholar 

  44. Sutton AG, et al. A randomized trial of rescue angioplasty versus a conservative approach for failed thrombolysis in ST-segment elevation myocardial infarction: the Middlesbrough Early Revascularization to Limit INfarction (MERLIN) trial. J Am Coll Cardiol. 2004;44(2):287–96.

    Article  PubMed  Google Scholar 

  45. Gershlick AH, et al. Rescue angioplasty after failed thrombolytic therapy for acute myocardial infarction. N Engl J Med. 2005;353(26):2758–68.

    Article  PubMed  CAS  Google Scholar 

  46. Wijeysundera HC, et al. Rescue angioplasty or repeat thrombolysis after failed fibrinolytic therapy for ST-segment myocardial infarction: a meta-analysis of randomized trials. J Am Coll Cardiol. 2007;49(4):422–30.

    Article  PubMed  Google Scholar 

  47. Antman EM, et al. 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee. Circulation. 2008;117(2):296–329.

    Article  PubMed  Google Scholar 

  48. Montalescot G, et al. Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label ATOLL Trial. Lancet. 2011;378(9792):693–703.

    Article  PubMed  CAS  Google Scholar 

  49. Montalescot G, et al. Enoxaparin in primary and facilitated percutaneous coronary intervention A formal prospective nonrandomized substudy of the FINESSE trial (Facilitated INtervention with Enhanced Reperfusion Speed to Stop Events). JACC Cardiovasc Interv. 2010;3(2):203–12.

    Article  PubMed  Google Scholar 

  50. Li YJ, et al. Low-molecular-weight heparin versus unfractionated heparin in acute ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention with drug-eluting stents. Am Heart J. 2010;159(4):684–90 e1.

    Article  PubMed  CAS  Google Scholar 

  51. Yusuf S, et al. Effects of fondaparinux on mortality and re-infarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial. JAMA. 2006;295(13):1519–30.

    Article  PubMed  CAS  Google Scholar 

  52. Stone GW, et al. Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med. 2008;358(21):2218–30.

    Article  PubMed  CAS  Google Scholar 

  53. Stone GW, et al. Bivalirudin for patients with acute coronary syndromes. N Engl J Med. 2006;355(21):2203–16.

    Article  PubMed  CAS  Google Scholar 

  54. Mehilli J, et al. Abciximab in patients with acute ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention after clopidogrel loading: a randomized double-blind trial. Circulation. 2009;119(14):1933–40.

    Article  PubMed  CAS  Google Scholar 

  55. Van’t Hof AW, et al. Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomised controlled trial. Lancet. 2008;372(9638):537–46.

    Article  Google Scholar 

  56. Valgimigli M, et al. Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trial. JAMA. 2008;299(15):1788–99.

    Article  PubMed  CAS  Google Scholar 

  57. De Luca G, et al. Benefits from small molecule administration as compared with abciximab among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-analysis. J Am Coll Cardiol. 2009;53(18):1668–73.

    Article  PubMed  Google Scholar 

  58. Sabatine MS, et al. Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study. JAMA. 2005;294(10):1224–32.

    Article  PubMed  CAS  Google Scholar 

  59. von Beckerath N, et al. Absorption, metabolization, and antiplatelet effects of 300-, 600-, and 900-mg loading doses of clopidogrel: results of the ISAR-CHOICE (Intracoronary Stenting and Antithrombotic Regimen: Choose Between 3 High Oral Doses for Immediate Clopidogrel Effect) Trial. Circulation. 2005;112(19):2946–50.

    Google Scholar 

  60. Mangiacapra F, et al. Comparison of 600 versus 300-mg Clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary coronary angioplasty. Am J Cardiol. 2010;106(9):1208–11.

    Article  PubMed  CAS  Google Scholar 

  61. Wiviott SD, et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2007;357(20):2001–15.

    Article  PubMed  CAS  Google Scholar 

  62. Wallentin L, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009;361(11):1045–57.

    Article  PubMed  CAS  Google Scholar 

  63. Forman MB, Stone GW, Jackson EK. Role of adenosine as adjunctive therapy in acute myocardial infarction. Cardiovasc Drug Rev. 2006;24(2):116–47.

    Article  PubMed  CAS  Google Scholar 

  64. Mahaffey KW, et al. Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction STudy of ADenosine (AMISTAD) trial. J Am Coll Cardiol. 1999;34(6):1711–20.

    Article  PubMed  CAS  Google Scholar 

  65. Kloner RA, et al. Impact of time to therapy and reperfusion modality on the efficacy of adenosine in acute myocardial infarction: the AMISTAD-2 trial. Eur Heart J. 2006;27(20):2400–5.

    Article  PubMed  CAS  Google Scholar 

  66. Ross AM, et al. A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II). J Am Coll Cardiol. 2005;45(11):1775–80.

    Article  PubMed  CAS  Google Scholar 

  67. Sianos G, et al. Angiographic stent thrombosis after routine use of drug-eluting stents in ST-segment elevation myocardial infarction: the importance of thrombus burden. J Am Coll Cardiol. 2007;50(7):573–83.

    Article  PubMed  CAS  Google Scholar 

  68. Svilaas T, et al. Thrombus aspiration during primary percutaneous coronary intervention. N Engl J Med. 2008;358(6):557–67.

    Article  PubMed  CAS  Google Scholar 

  69. Vlaar PJ, et al. Cardiac death and re-infarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): a 1-year follow-up study. Lancet. 2008;371(9628):1915–20.

    Article  PubMed  Google Scholar 

  70. Vlaar PJ, et al. A comparison of 2 thrombus aspiration devices with histopathological analysis of retrieved material in patients presenting with ST-segment elevation myocardial infarction. JACC Cardiovasc Interv. 2008;1(3):258–64.

    Article  PubMed  Google Scholar 

  71. Sardella G, et al. Thrombus aspiration during primary percutaneous coronary intervention improves myocardial reperfusion and reduces infarct size: the EXPIRA (thrombectomy with export catheter in infarct-related artery during primary percutaneous coronary intervention) prospective, randomized trial. J Am Coll Cardiol. 2009;53(4):309–15.

    Article  PubMed  Google Scholar 

  72. Bavry AA, Kumbhani DJ, Bhatt DL. Role of adjunctive thrombectomy and embolic protection devices in acute myocardial infarction: a comprehensive meta-analysis of randomized trials. Eur Heart J. 2008;29(24):2989–3001.

    Article  PubMed  Google Scholar 

  73. Burzotta F, et al. Clinical impact of thrombectomy in acute ST-elevation myocardial infarction: an individual patient-data pooled analysis of 11 trials. Eur Heart J. 2009;30(18):2193–203.

    Article  PubMed  Google Scholar 

  74. Ali A, et al. Rheolytic thrombectomy with percutaneous coronary intervention for infarct size reduction in acute myocardial infarction: 30-day results from a multicenter randomized study. J Am Coll Cardiol. 2006;48(2):244–52.

    Article  PubMed  Google Scholar 

  75. Migliorini A, et al. Comparison of AngioJet rheolytic thrombectomy before direct infarct artery stenting with direct stenting alone in patients with acute myocardial infarction. The JETSTENT trial. J Am Coll Cardiol. 2010;56(16):1298–306.

    Article  PubMed  Google Scholar 

  76. Zhao ZQ, Vinten-Johansen J. Postconditioning: reduction of reperfusion-induced injury. Cardiovasc Res. 2006;70(2):200–11.

    Article  PubMed  CAS  Google Scholar 

  77. Staat P, et al. Postconditioning the human heart. Circulation. 2005;112(14):2143–8.

    Article  PubMed  Google Scholar 

  78. Thibault H, et al. Long-term benefit of postconditioning. Circulation. 2008;117(8):1037–44.

    Article  PubMed  CAS  Google Scholar 

  79. Oneill W, et al. A prospective randomized trial of mild systemic hypothermia during percutaneous coronary intervention therapy of ST elevation myocardial infarction. Presented at the transcatheter cariovascular therapeutics conference, Washington, DC; 2004.

    Google Scholar 

  80. Grines C, et al. Intravascular cooling adjunctive to PCI. Presented at the transcatheter cardiovascular therapeutics conference, Washington, DC; 2004.

    Google Scholar 

  81. Oneill W. Novel myocardial preservation therapies: frustrations and future promise. Presented at the transcatheter cardovascular therapeutics conference, Washington, DC; 2006.

    Google Scholar 

  82. Gotberg M, et al. A pilot study of rapid cooling by cold saline and endovascular cooling. Cathet Cardiovasc Interv. 2010;3(5):400–7.

    Article  Google Scholar 

  83. Stone GW, et al. Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial. JAMA. 2005;293(9):1063–72.

    Article  PubMed  CAS  Google Scholar 

  84. Brueck M, et al. A randomized comparison of transradial versus transfemoral approach for coronary angiography and angioplasty. JACC Cardiovasc Interv. 2009;2(11):1047–54.

    Article  PubMed  Google Scholar 

  85. Neill J, et al. Comparison of radiation dose and the effect of operator experience in femoral and radial arterial access for coronary procedures. Am J Cardiol. 2010;106(7):936–40.

    Article  PubMed  Google Scholar 

  86. Sciahbasi A, et al. Evaluation of the “learning curve” for left and right radial approach during percutaneous coronary procedures. Am J Cardiol. 2011;108(2):185–8.

    Article  PubMed  Google Scholar 

  87. Looi JL, Cave A, El-Jack S. Learning curve in transradial coronary angiography. Am J Cardiol. 2011;108(8):1092–5.

    Article  PubMed  Google Scholar 

  88. Jolly SS, et al. Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial. Lancet. 2011;377(9775):1409–20.

    Article  PubMed  Google Scholar 

  89. Thiele H, et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med. 2012;367(14):1287–96.

    Article  PubMed  CAS  Google Scholar 

  90. Seyfarth M, et al. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol. 2008;52(19):1584–8.

    Article  PubMed  Google Scholar 

  91. Remmelink M, et al. Effects of mechanical left ventricular unloading by Impella on left ventricular dynamics in high-risk and primary percutaneous coronary intervention patients. Catheter Cardiovasc Interv. 2010;75(2):187–94.

    Article  PubMed  Google Scholar 

  92. Sjauw KD, et al. Supported high-risk percutaneous coronary intervention with the Impella 2.5 device the Europella registry. J Am Coll Cardiol. 2009;54(25):2430–4.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology, Minneapolis Heart Institute, 920 East 28th St, Ste. 620, Minneapolis, MN, 55417, USA

    Nur Jamal MD, Ron Reiter MD & M. Nicholas Burke MD

Authors
  1. Nur Jamal MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ron Reiter MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Nicholas Burke MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Nicholas Burke MD .

Editor information

Editors and Affiliations

  1. Department of Medicine, Cardiology Section, Director, Cardiovascular Catheterization and Intervention, Yale New Haven Hospital, Director, Invasive Cardiology and Vascular Medicine,, New Haven, Connecticut, USA

    Craig A. Thompson

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag London

About this chapter

Cite this chapter

Jamal, N., Reiter, R., Burke, M.N. (2014). Interventional Management of Acute Myocardial Infarction. In: Thompson, C. (eds) Textbook of Cardiovascular Intervention. Springer, London. https://doi.org/10.1007/978-1-4471-4528-8_16

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-4528-8_16

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-4527-1

  • Online ISBN: 978-1-4471-4528-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation